Drugs / Activated-Dendritic Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03086564 | May 2017 → May 2020 | hepatocellular carcinoma | Yuehua Huang | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Activated-Dendritic Cells | “Experimental groups will be given TACE as well as Activated-Dendritic Cells” NCT03086564 ↗ |
| Route | Intravenous | “Activated-Dendritic Cells(1-2\*10\^8,intravenous drip)” NCT03086564 ↗ |